CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs

Negative
AI Analysis

Summary

Analysts report that private deals between the Trump administration and drugmakers allow companies to keep Medicare prices high while reducing Medicaid prices, potentially undermining broader drug cost containment efforts.

Importance:4/10
Sentiment:
-0.60
drug pricingMedicareMedicaidpolicyTrump administrationregulatory

Read the original article

Published by STAT News on September 2, 2026 8:30 AM

Read Original